A good share of all the mutations associated with human diseases cause mild protein destabilization. Drugs known as "pharmacological chaperones" can stabilize these mutants and rescue their activity. Given a gene, some mutations respond, others do not. Usually compounds that can stabilize mutants, stabilize the wild type protein too. We apply this approach to Fabry disease, Pompe disease and to PMM2-CDG, a disorder of glysosilation with no cure at present.
Thermodynamics for rare diseases
Giuseppina Andreotti;
2014
Abstract
A good share of all the mutations associated with human diseases cause mild protein destabilization. Drugs known as "pharmacological chaperones" can stabilize these mutants and rescue their activity. Given a gene, some mutations respond, others do not. Usually compounds that can stabilize mutants, stabilize the wild type protein too. We apply this approach to Fabry disease, Pompe disease and to PMM2-CDG, a disorder of glysosilation with no cure at present.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
